JP2023053978A5 - - Google Patents

Download PDF

Info

Publication number
JP2023053978A5
JP2023053978A5 JP2023010162A JP2023010162A JP2023053978A5 JP 2023053978 A5 JP2023053978 A5 JP 2023053978A5 JP 2023010162 A JP2023010162 A JP 2023010162A JP 2023010162 A JP2023010162 A JP 2023010162A JP 2023053978 A5 JP2023053978 A5 JP 2023053978A5
Authority
JP
Japan
Prior art keywords
composition
peptide
group
poly
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023010162A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023053978A (ja
Filing date
Publication date
Priority claimed from JP2020029398A external-priority patent/JP7284726B2/ja
Application filed filed Critical
Publication of JP2023053978A publication Critical patent/JP2023053978A/ja
Publication of JP2023053978A5 publication Critical patent/JP2023053978A5/ja
Priority to JP2024170459A priority Critical patent/JP2025010144A/ja
Pending legal-status Critical Current

Links

JP2023010162A 2014-03-26 2023-01-26 環状プロサポシンペプチドおよびその使用 Pending JP2023053978A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024170459A JP2025010144A (ja) 2014-03-26 2024-09-30 環状プロサポシンペプチドおよびその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461970853P 2014-03-26 2014-03-26
US61/970,853 2014-03-26
JP2020029398A JP7284726B2 (ja) 2014-03-26 2020-02-25 環状プロサポシンペプチドおよびその使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020029398A Division JP7284726B2 (ja) 2014-03-26 2020-02-25 環状プロサポシンペプチドおよびその使用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024170459A Division JP2025010144A (ja) 2014-03-26 2024-09-30 環状プロサポシンペプチドおよびその使用

Publications (2)

Publication Number Publication Date
JP2023053978A JP2023053978A (ja) 2023-04-13
JP2023053978A5 true JP2023053978A5 (https=) 2023-08-18

Family

ID=54196396

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2016559300A Active JP6727129B2 (ja) 2014-03-26 2015-03-26 環状プロサポシンペプチドおよびその使用
JP2020029398A Active JP7284726B2 (ja) 2014-03-26 2020-02-25 環状プロサポシンペプチドおよびその使用
JP2023010162A Pending JP2023053978A (ja) 2014-03-26 2023-01-26 環状プロサポシンペプチドおよびその使用
JP2024170459A Pending JP2025010144A (ja) 2014-03-26 2024-09-30 環状プロサポシンペプチドおよびその使用

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2016559300A Active JP6727129B2 (ja) 2014-03-26 2015-03-26 環状プロサポシンペプチドおよびその使用
JP2020029398A Active JP7284726B2 (ja) 2014-03-26 2020-02-25 環状プロサポシンペプチドおよびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024170459A Pending JP2025010144A (ja) 2014-03-26 2024-09-30 環状プロサポシンペプチドおよびその使用

Country Status (6)

Country Link
US (5) US10646541B2 (https=)
EP (2) EP3122369B1 (https=)
JP (4) JP6727129B2 (https=)
CN (2) CN106659764B (https=)
AU (4) AU2015235978B2 (https=)
WO (1) WO2015148801A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2692171C (en) 2007-06-22 2019-10-22 Randolph Watnick Methods and uses thereof of prosaposin
AU2015235978B2 (en) 2014-03-26 2019-08-08 Children's Medical Center Corporation Cyclic prosaposin peptides and uses thereof
US12331320B2 (en) 2018-10-10 2025-06-17 The Research Foundation For The State University Of New York Genome edited cancer cell vaccines
CN118435060A (zh) * 2021-12-17 2024-08-02 维吉奥治疗公司 用于治疗癌症的方法和组合物

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3832253A (en) 1973-03-21 1974-08-27 Baxter Laboratories Inc Method of making an inflatable balloon catheter
US4667014A (en) 1983-03-07 1987-05-19 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists
US4452775A (en) 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
CA1200416A (en) 1983-05-13 1986-02-11 Societe Des Produits Nestle S.A. Food process
GB8518144D0 (en) 1985-07-18 1985-08-21 Univ Belfast Solid phase peptide synthesis
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US4794150A (en) 1987-03-11 1988-12-27 Samuel Steel Synthesis of peptide analogs
US5541297A (en) 1988-04-01 1996-07-30 Immunomedics, Inc. Therapeutic conjugates of toxins and drugs
US5180816A (en) 1988-08-24 1993-01-19 Centocor One vial method for labeling protein/linker conjugates with technetium-99M
US5221754A (en) 1989-06-09 1993-06-22 Research Corporation Technologies, Inc. Reagents for rapid peptide synthesis
US5766897A (en) 1990-06-21 1998-06-16 Incyte Pharmaceuticals, Inc. Cysteine-pegylated proteins
JPH04167172A (ja) 1990-10-31 1992-06-15 Nec Corp ベクトルプロセッサ
US5565332A (en) 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
WO1994012520A1 (en) 1992-11-20 1994-06-09 Enzon, Inc. Linker for linked fusion polypeptides
PT710243E (pt) 1993-06-29 2000-11-30 Ferring Bv Sintese melhorada de peptidos ciclicos.
US5571787A (en) 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor
US5700909A (en) 1993-07-30 1997-12-23 The Regents Of The University Of California Prosaposin and cytokine-derived peptides
US5552471A (en) 1994-08-17 1996-09-03 The Perkin-Elmer Corporation Solid support reagents for the synthesis of 3'-Nitrogen containing polynucleotides
US6001966A (en) 1995-10-19 1999-12-14 Proligo Llc Method for solution phase synthesis of oligonucleotides and peptides
US5817752A (en) 1996-06-06 1998-10-06 La Jolla Pharmaceutical Company Cyclic polypeptides comprising a thioether linkage and methods for their preparation
US7176282B1 (en) 1996-09-09 2007-02-13 Zealand Pharma A/S Solid-phase peptide synthesis and agent for use in such synthesis
CA2304108A1 (en) 1997-09-09 1999-03-18 The Regents Of The University Of California Inhibition of apoptotis using prosaposin receptor agonists
WO1999045026A1 (en) 1998-03-05 1999-09-10 Chiron Corporation Method for increasing the serum half-life of a biologically active molecule
US7094943B2 (en) 1998-04-27 2006-08-22 Hubert Köster Solution phase biopolymer synthesis
US6638911B1 (en) * 1998-05-05 2003-10-28 Adherex Technologies Inc. Compounds and methods for modulating desmosomal cadherin-mediated functions
US6500431B1 (en) 1998-07-13 2002-12-31 University Of Southern California Inhibitors of angiogenesis and tumor growth
AUPP616498A0 (en) 1998-09-25 1998-10-15 University Of Queensland, The Synthesis of cyclic peptides
US6706252B1 (en) 1998-10-30 2004-03-16 Rx/Ibr Corporation Method of treating disease with radioisotopes conjugated to bioactive substances
US20020177551A1 (en) 2000-05-31 2002-11-28 Terman David S. Compositions and methods for treatment of neoplastic disease
US20020168639A1 (en) 2000-09-22 2002-11-14 Muraca Patrick J. Profile array substrates
CA2422707A1 (en) 2000-10-05 2002-04-11 Ares Trading S.A. Regioselective liquid phase pegylation
EP1514107B1 (en) 2002-06-03 2013-05-15 The Institute for Systems Biology Methods for quantitative proteome analysis of glycoproteins
US20040219609A1 (en) 2002-07-12 2004-11-04 Day Anthony G. Methods for modulating proteins not previously known as proteases
US7166691B2 (en) 2002-12-20 2007-01-23 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Saposin C and receptors as targets for treatment of benign and malignant disorders
US20060275274A1 (en) 2003-03-26 2006-12-07 Daria Onichtchouk Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome
US7610156B2 (en) 2003-03-31 2009-10-27 Xencor, Inc. Methods for rational pegylation of proteins
US7834147B2 (en) 2003-04-28 2010-11-16 Childrens Hospital Medical Center Saposin C-DOPS: a novel anti-tumor agent
GB0318205D0 (en) 2003-08-02 2003-09-03 Albachem Ltd Synthetic method
CA2604180A1 (en) 2005-04-29 2006-11-09 (Osi) Eyetech, Inc. Vegf variants
EP1938104A2 (en) 2005-10-17 2008-07-02 Institute for Systems Biology Tissue-and serum-derived glycoproteins and methods of their use
US20080090760A2 (en) 2005-12-09 2008-04-17 Todd Hembrough Compositions and Methods for Inhibiting Cellular Proliferation
CA2673229A1 (en) 2006-12-29 2008-07-10 F. Hoffmann-La Roche Ag Methods for the synthesis of cyclic peptides
CA2692171C (en) * 2007-06-22 2019-10-22 Randolph Watnick Methods and uses thereof of prosaposin
WO2011084685A2 (en) 2009-12-17 2011-07-14 Children's Medical Center Corporation Saposin-a derived peptides and uses thereof
US8027291B2 (en) 2007-09-27 2011-09-27 Wireless Technology Solutions Llc Method and apparatus for transmitting transport channels over a physical channel of a cellular communication system
WO2010014616A2 (en) 2008-07-28 2010-02-04 Children's Medical Center Corporation Prominin-1 peptide fragments and uses thereof
EP3560509B1 (en) * 2011-12-22 2024-01-31 Children's Medical Center Corporation Saposin-a derived peptides and uses thereof
JP6457999B2 (ja) * 2013-03-14 2019-01-23 ザ チルドレンズ メディカル センター コーポレーション 処置に関してがんの対象を識別するためのｃｄ３６の使用
AU2015235978B2 (en) 2014-03-26 2019-08-08 Children's Medical Center Corporation Cyclic prosaposin peptides and uses thereof

Similar Documents

Publication Publication Date Title
JP2023053978A5 (https=)
CN1729018B (zh) G-csf偶联物
AU2002325819B2 (en) G-CSF Conjugates
EP1375518B1 (en) Anti-osteopontin antibody and use thereof
DE69319740T2 (de) Verbesserte synthese von polymer-bioaktiven-konjugaten
Zhang et al. Recent progress in capturing and neutralizing inflammatory cytokines
JP2005512507A5 (https=)
AU2002325819A1 (en) G-CSF Conjugates
HUP0203751A2 (hu) G-CSF Konjugátumok
JP2013513374A (ja) シトルリン化エピトープに対する抗炎症剤
EP2391651B1 (en) Eotaxin-2 (ccl24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders
ES2617713T3 (es) Conjugados de derivado de polietilenglicol, catecol y proteína o péptido, y procedimiento de preparación de los mismos
JP2017512799A5 (https=)
JP2023527352A5 (https=)
IL310372A (en) Il15/il15r alpha heterodimeric fc-fusion proteins for the treatment of blood cancers
US20130109614A1 (en) Antagonists for diseases induced by cells with high-affinity elr-cxc chemokine receptor proteins
JP2022119899A5 (https=)
CN116102621A (zh) 用于改善活性蛋白或多肽性能的人工重组蛋白及其应用
Keizer et al. Human CC chemokine I-309, structural consequences of the additional disulfide bond
JP2008542311A5 (https=)
Cho et al. Zwitterionic polymer with minimal reactivity against PEG antibodies to enhance the therapeutic effects of cytokine-targeting DNA aptamer
EP2279756A2 (en) Method for shielding functional sites or epitopes on proteins
RU2017104284A (ru) Выделенные полипептиды cd44 и их применение
WO2002081520A2 (en) Single chain dimeric polypeptides derived from the vegf family
Gschwandtner et al. Glycosaminoglycan silencing by engineered CXCL12 variants